Law360, New York (April 24, 2009) -- A federal judge has approved a $250 million settlement in the long-running antitrust class action that accused Abbott Laboratories and its French partner Fournier Industrie et Sante of conspiring to block generics makers from breaking into the lucrative market for the high-cholesterol drug TriCor.
The approval, granted Thursday by Judge Sue Robinson of the U.S. District Court for the District of Delaware, resolves the last of claims from the class of drug sellers....
